La courbe ROC évalue-t-elle des facteurs de risque ?
Non, elle évalue la performance des tests, pas les facteurs de risque eux-mêmes.
Facteurs de risqueTests diagnostiquesÉvaluation
#2
Comment la courbe ROC aide-t-elle à identifier des facteurs de risque ?
En évaluant des tests qui détectent des maladies liées à des facteurs de risque spécifiques.
IdentificationFacteurs de risqueTests de dépistage
#3
Les facteurs de risque influencent-ils la courbe ROC ?
Oui, la prévalence des facteurs de risque peut affecter la sensibilité et la spécificité des tests.
PrévalenceFacteurs de risqueSensibilité
#4
Peut-on utiliser la courbe ROC pour évaluer des tests liés à des facteurs de risque ?
Oui, elle permet d'évaluer l'efficacité des tests pour détecter des maladies liées à ces facteurs.
ÉvaluationFacteurs de risqueTests diagnostiques
#5
La courbe ROC aide-t-elle à prioriser les facteurs de risque ?
Oui, en identifiant les tests les plus fiables, elle aide à prioriser les facteurs de risque à surveiller.
PriorisationFacteurs de risqueTests de dépistage
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Courbe ROC : Questions médicales les plus fréquentes",
"headline": "Courbe ROC : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Courbe ROC : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-27",
"dateModified": "2025-04-23",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Courbe ROC"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Méthodologie en recherche épidémiologique",
"url": "https://questionsmedicales.fr/mesh/D015340",
"about": {
"@type": "MedicalCondition",
"name": "Méthodologie en recherche épidémiologique",
"code": {
"@type": "MedicalCode",
"code": "D015340",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.445"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Courbe ROC",
"alternateName": "ROC Curve",
"code": {
"@type": "MedicalCode",
"code": "D012372",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Zhen Chen",
"url": "https://questionsmedicales.fr/author/Zhen%20Chen",
"affiliation": {
"@type": "Organization",
"name": "Biostatistics and Bioinformatics Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, MD, USA."
}
},
{
"@type": "Person",
"name": "Oliver Kuss",
"url": "https://questionsmedicales.fr/author/Oliver%20Kuss",
"affiliation": {
"@type": "Organization",
"name": "Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany."
}
},
{
"@type": "Person",
"name": "Annika Hoyer",
"url": "https://questionsmedicales.fr/author/Annika%20Hoyer",
"affiliation": {
"@type": "Organization",
"name": "Biostatistics and Medical Biometry, Medical School OWL, Bielefeld University, Bielefeld, Germany."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": "School of Mathematics and Statistics, North China University of Water Resources and Electric Power, Zhengzhou, China."
}
},
{
"@type": "Person",
"name": "Soutik Ghosal",
"url": "https://questionsmedicales.fr/author/Soutik%20Ghosal",
"affiliation": {
"@type": "Organization",
"name": "Biostatistics and Bioinformatics Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, MD, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "AUCReshaping: improved sensitivity at high-specificity.",
"datePublished": "2023-11-30",
"url": "https://questionsmedicales.fr/article/38036602",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-48482-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Meta-analysis assessing the sensitivity and specificity of",
"datePublished": "2023-03-18",
"url": "https://questionsmedicales.fr/article/36934977",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ahj.2023.03.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sensitivity and specificity of Varian Halcyon's portal dosimetry for plan-specific pre-treatment QA.",
"datePublished": "2023-04-22",
"url": "https://questionsmedicales.fr/article/37086428",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/acm2.14001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Specific recognition and sensitive quantification of mRNA splice variants",
"datePublished": "2023-11-06",
"url": "https://questionsmedicales.fr/article/37818948",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1039/d3an01382k"
}
},
{
"@type": "ScholarlyArticle",
"name": "Estimating stage-specific sensitivity for cancer screening tests.",
"datePublished": "2023-02-03",
"url": "https://questionsmedicales.fr/article/36734139",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/09691413231154801"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Santé publique",
"item": "https://questionsmedicales.fr/mesh/D011634"
},
{
"@type": "ListItem",
"position": 4,
"name": "Méthodes épidémiologiques",
"item": "https://questionsmedicales.fr/mesh/D004812"
},
{
"@type": "ListItem",
"position": 5,
"name": "Méthodologie en recherche épidémiologique",
"item": "https://questionsmedicales.fr/mesh/D015340"
},
{
"@type": "ListItem",
"position": 6,
"name": "Courbe ROC",
"item": "https://questionsmedicales.fr/mesh/D012372"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Courbe ROC - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Courbe ROC",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Courbe ROC",
"description": "Qu'est-ce qu'une courbe ROC ?\nComment interpréter une courbe ROC ?\nQuelle est l'aire sous la courbe ROC ?\nQuels tests utilisent la courbe ROC ?\nQuelle est l'importance de la courbe ROC ?",
"url": "https://questionsmedicales.fr/mesh/D012372?mesh_terms=Sensitivity+and+Specificity&page=1#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Courbe ROC",
"description": "Les courbes ROC montrent-elles des symptômes ?\nPeut-on utiliser la courbe ROC pour des symptômes spécifiques ?\nComment la courbe ROC aide-t-elle au diagnostic des symptômes ?\nLes symptômes influencent-ils la courbe ROC ?\nPeut-on comparer des symptômes avec la courbe ROC ?",
"url": "https://questionsmedicales.fr/mesh/D012372?mesh_terms=Sensitivity+and+Specificity&page=1#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Courbe ROC",
"description": "La courbe ROC aide-t-elle à la prévention des maladies ?\nComment la courbe ROC influence-t-elle les programmes de prévention ?\nPeut-on utiliser la courbe ROC pour des stratégies de prévention ?\nLes tests de dépistage sont-ils évalués par la courbe ROC ?\nLa courbe ROC peut-elle aider à prioriser les interventions préventives ?",
"url": "https://questionsmedicales.fr/mesh/D012372?mesh_terms=Sensitivity+and+Specificity&page=1#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Courbe ROC",
"description": "La courbe ROC aide-t-elle à choisir un traitement ?\nPeut-on utiliser la courbe ROC pour évaluer des traitements ?\nComment la courbe ROC influence-t-elle les décisions de traitement ?\nLes résultats des tests influencent-ils les traitements ?\nLa courbe ROC est-elle utilisée dans les essais cliniques ?",
"url": "https://questionsmedicales.fr/mesh/D012372?mesh_terms=Sensitivity+and+Specificity&page=1#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Courbe ROC",
"description": "La courbe ROC peut-elle prédire des complications ?\nComment la courbe ROC aide-t-elle à éviter des complications ?\nLes complications influencent-elles la courbe ROC ?\nPeut-on utiliser la courbe ROC pour évaluer des risques de complications ?\nLa courbe ROC est-elle utile pour les complications post-opératoires ?",
"url": "https://questionsmedicales.fr/mesh/D012372?mesh_terms=Sensitivity+and+Specificity&page=1#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Courbe ROC",
"description": "La courbe ROC évalue-t-elle des facteurs de risque ?\nComment la courbe ROC aide-t-elle à identifier des facteurs de risque ?\nLes facteurs de risque influencent-ils la courbe ROC ?\nPeut-on utiliser la courbe ROC pour évaluer des tests liés à des facteurs de risque ?\nLa courbe ROC aide-t-elle à prioriser les facteurs de risque ?",
"url": "https://questionsmedicales.fr/mesh/D012372?mesh_terms=Sensitivity+and+Specificity&page=1#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Qu'est-ce qu'une courbe ROC ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un graphique qui montre la sensibilité et la spécificité d'un test à différents seuils."
}
},
{
"@type": "Question",
"name": "Comment interpréter une courbe ROC ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une courbe proche du coin supérieur gauche indique un bon test, tandis qu'une diagonale indique un test aléatoire."
}
},
{
"@type": "Question",
"name": "Quelle est l'aire sous la courbe ROC ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'aire sous la courbe (AUC) quantifie la performance globale d'un test, allant de 0 à 1."
}
},
{
"@type": "Question",
"name": "Quels tests utilisent la courbe ROC ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est utilisée pour évaluer des tests de dépistage, comme ceux pour le diabète ou le cancer."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de la courbe ROC ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle aide à choisir le meilleur seuil de décision pour maximiser la détection des maladies."
}
},
{
"@type": "Question",
"name": "Les courbes ROC montrent-elles des symptômes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elles évaluent la performance des tests, pas les symptômes eux-mêmes."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser la courbe ROC pour des symptômes spécifiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut aider à évaluer des tests pour des symptômes particuliers, comme la douleur thoracique."
}
},
{
"@type": "Question",
"name": "Comment la courbe ROC aide-t-elle au diagnostic des symptômes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet de déterminer la fiabilité d'un test pour des symptômes spécifiques en ajustant le seuil."
}
},
{
"@type": "Question",
"name": "Les symptômes influencent-ils la courbe ROC ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, car la prévalence des symptômes affecte la sensibilité et la spécificité des tests."
}
},
{
"@type": "Question",
"name": "Peut-on comparer des symptômes avec la courbe ROC ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en utilisant des tests différents pour des symptômes similaires, on peut comparer leur efficacité."
}
},
{
"@type": "Question",
"name": "La courbe ROC aide-t-elle à la prévention des maladies ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, en évaluant l'efficacité des tests de dépistage qui peuvent prévenir des maladies."
}
},
{
"@type": "Question",
"name": "Comment la courbe ROC influence-t-elle les programmes de prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet d'identifier les tests les plus efficaces pour le dépistage précoce dans les programmes."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser la courbe ROC pour des stratégies de prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, pour évaluer les tests qui aident à identifier les populations à risque pour des interventions."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage sont-ils évalués par la courbe ROC ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la courbe ROC est un outil clé pour évaluer la performance des tests de dépistage."
}
},
{
"@type": "Question",
"name": "La courbe ROC peut-elle aider à prioriser les interventions préventives ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en identifiant les tests les plus fiables, elle aide à prioriser les interventions de santé."
}
},
{
"@type": "Question",
"name": "La courbe ROC aide-t-elle à choisir un traitement ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, en évaluant l'efficacité des tests qui guident les décisions de traitement."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser la courbe ROC pour évaluer des traitements ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle évalue les tests diagnostiques, pas les traitements eux-mêmes."
}
},
{
"@type": "Question",
"name": "Comment la courbe ROC influence-t-elle les décisions de traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet de choisir des tests plus fiables, ce qui peut influencer le choix du traitement."
}
},
{
"@type": "Question",
"name": "Les résultats des tests influencent-ils les traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests fiables peuvent mener à des traitements plus appropriés et efficaces."
}
},
{
"@type": "Question",
"name": "La courbe ROC est-elle utilisée dans les essais cliniques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, pour évaluer la performance des tests utilisés dans les essais cliniques pour des traitements."
}
},
{
"@type": "Question",
"name": "La courbe ROC peut-elle prédire des complications ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle évalue la performance des tests, pas les complications elles-mêmes."
}
},
{
"@type": "Question",
"name": "Comment la courbe ROC aide-t-elle à éviter des complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "En identifiant des tests fiables, elle permet un diagnostic précoce, réduisant le risque de complications."
}
},
{
"@type": "Question",
"name": "Les complications influencent-elles la courbe ROC ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, car la prévalence des complications peut affecter la sensibilité des tests."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser la courbe ROC pour évaluer des risques de complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en évaluant des tests qui prédisent des complications, on peut ajuster les soins."
}
},
{
"@type": "Question",
"name": "La courbe ROC est-elle utile pour les complications post-opératoires ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut évaluer des tests qui prédisent des complications après une intervention chirurgicale."
}
},
{
"@type": "Question",
"name": "La courbe ROC évalue-t-elle des facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle évalue la performance des tests, pas les facteurs de risque eux-mêmes."
}
},
{
"@type": "Question",
"name": "Comment la courbe ROC aide-t-elle à identifier des facteurs de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "En évaluant des tests qui détectent des maladies liées à des facteurs de risque spécifiques."
}
},
{
"@type": "Question",
"name": "Les facteurs de risque influencent-ils la courbe ROC ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la prévalence des facteurs de risque peut affecter la sensibilité et la spécificité des tests."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser la courbe ROC pour évaluer des tests liés à des facteurs de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle permet d'évaluer l'efficacité des tests pour détecter des maladies liées à ces facteurs."
}
},
{
"@type": "Question",
"name": "La courbe ROC aide-t-elle à prioriser les facteurs de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en identifiant les tests les plus fiables, elle aide à prioriser les facteurs de risque à surveiller."
}
}
]
}
]
}
Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China. Electronic address: zhouylivy@aliyun.com.
The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China.
The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China. Electronic address: ningjeny@126.com.
Central Laboratory, Female Center for Medical Studies and Scientific Section, King Saud University, P. O Box 22452, Riyadh, KSA, 11495, Saudi Arabia. afafkelansary@gmail.com.
Autism Research and Treatment Center, Riyadh, Saudi Arabia. afafkelansary@gmail.com.
Department of Statistics, Stanford University, 390 Serra Mall, Stanford University, Stanford, CA, USA and Ragon Institute of MGH, MIT and Harvard, 400 Technology Square, Cambridge, MA, USA.
Department of Statistics, Stanford University, 390 Serra Mall, Stanford University, Stanford, CA, USA and Ragon Institute of MGH, MIT and Harvard, 400 Technology Square, Cambridge, MA, USA.
Department of Statistics, Stanford University, 390 Serra Mall, Stanford University, Stanford, CA, USA and Ragon Institute of MGH, MIT and Harvard, 400 Technology Square, Cambridge, MA, USA.
Departamento de Estatística e Investigación Operativa, Centro de Investigacións Biomédicas (CINBIO), Universidade de Vigo, and Centro de Investigación e Tecnoloxía Matemática de Galicia (CITMAGA), Vigo, Spain.
The evaluation of deep-learning (DL) systems typically relies on the Area under the Receiver-Operating-Curve (AU-ROC) as a performance metric. However, AU-ROC, in its holistic form, does not sufficien...
The use of...
To estimate the summary sensitivity and specificity of...
Studies were included if PET/CT was performed for suspicion of PVE and IPD of both the PET/CT result and final diagnosis defined by a gold-standard assessment was available. There were 3 possible fina...
Seventeen studies were included with IPD available for 537 patients (from 538 scans). The summary sensitivity and specificity were 85% (95% CI 74.2%-91.8%) and 86.5% (95% CI 75.8%-92.9%) respectively ...
Developed as a plan-specific pre-treatment QA tool, Varian portal dosimetry promises a fast, high-resolution, and integrated QA solution. In this study, the agreement between predicted fluence and mea...
All patient plans and the corresponding verification plans were generated within the Eclipse treatment planning system. Four representative plans of different treatment sites (prostate, prostate with ...
Predicted and acquired portal dosimetry fluences demonstrated a high agreement evident by average gamma passing rates for the clinical patient plans of 99.90%, 96.64%, and 91.87% for γ...
Owing to the high achievable spatial resolution, portal dosimetry at the Halcyon can reliably be deployed as plan-specific pre-treatment QA tool to screen for errors. It is recommended to support the ...
Specific recognition and sensitive quantification of mRNA alternative splice variants have been a necessity for exploring the regulatory mechanism of RNA splicing and revealing the association between...
When evaluating potential new cancer screening modalities, estimating sensitivity, especially for early-stage cases, is critical. There are methods to approximate stage-specific sensitivity in asympto...
We fit natural history models to lung and ovarian cancer screening data that permitted estimation of stage-specific (early/late) true sensitivity, defined as the probability subjects screened in the g...
Stage-specific true sensitivities estimated by the lung cancer natural history model were 47% (early) and 63% (late). Simulation results for the prospective setting gave estimated sensitivities of 81%...
Existing methods for approximating stage-specific sensitivity in both prospective and retrospective scenarios are unsatisfactory; improvements are needed before they can be considered to be reliable....
Recombinant proteins in complex solutions are typically detected with tag-specific antibodies in Western blots. Here we describe an antibody-free alternative in which tagged proteins are detected dire...
Children with cancer often present with general and nonspecific symptoms leading to initial diagnostic workup inclusive of clinical imaging. Various sequences of magnetic resonance imaging (MRI) are b...
Enzyme-linked immunosorbent assays (ELISAs) are a cornerstone of modern molecular detection, but the technique still faces notable challenges. One of the biggest problems is discriminating true signal...
To evaluate the sensitivity and specificity of the ABCD progression display for keratoconus progression....
Data was collected from patients that underwent at least two Pentacam assessments 6 months apart. Sensitivity and specificity were calculated for the ABCD progression display. Progression was defined ...
Thirty eyes were evaluated over a median time of 10.3 months. Progression by criterion 1 resulted in a sensitivity of 61.9% and specificity of 88.9%. Progression by criterion 2 resulted in higher sens...
The ABCD progression display can assess keratoconus progression with high sensitivity and specificity, thus assisting the patients' decision-making process. The D parameter did not contribute to the s...
To systematically evaluate the evidence for the reliability, sensitivity and specificity of existing measures of vowel-initial voice onset....
A literature search was conducted across electronic databases for published studies (MEDLINE, EMBASE, Scopus, Web of Science, CINAHL, PubMed Central, IEEE Xplore) and grey literature (ProQuest for unp...
The search retrieved 6,983 records. Titles and abstracts were screened against the inclusion criteria by two independent reviewers, with a third reviewer responsible for conflict resolution. Thirty-fi...
A range of vowel-initial voice onset measurements have been applied throughout the literature, however, there is a lack of evidence regarding their sensitivity, specificity and reliability in the dete...